BAM
AMED

Blueshift Asset Management’s Amedisys AMED Stock Holding History

Blueshift Asset Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,317
Closed -$244K – 586
2022
Q2 		$244K Buy
+2,317
New +$296K 0.04% 515
2021
Q4 		– Sell
-3,816
Closed -$569K – 829
2021
Q3 		$569K Buy
+3,816
New +$793K 0.03% 579
2019
Q3 		– Sell
-1,671
Closed -$203K – 708
2019
Q2 		$203K Sell
1,671
-2,107
-56% -$250K 0.03% 652
2019
Q1 		$466K Buy
+3,778
New +$474K 0.07% 411

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Blueshift Asset Management's AMED Position: Q3 2022 in Review

Blueshift Asset Management sold out of Amedisys (AMED) in Q3 2022, closing a stake of 2,317 shares — an estimated $244K sold.

Blueshift Asset Management first reported a position in AMED in Q1 2019 and held it in 4 quarters. The position peaked at $569K in Q3 2021. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • Blueshift Asset Management reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
  • Blueshift Asset Management sold 2,317 Amedisys shares in Q3 2022, an estimated $244K.
  • Blueshift Asset Management first reported a position in Amedisys in Q1 2019 and held it in 4 quarters.
  • Blueshift Asset Management's Amedisys position peaked at $569K in Q3 2021.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Blueshift Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.